Encouraging results of low-dose etoposide in the treatment of early-onset hemophagocytic syndrome following allogeneic hematopoietic stem cell transplantation.
Koyama
Maho
M
Sawada
Akihisa
A
Yasui
Masahiro
M
Inoue
Masami
M
Kawa
Keisei
K
D000293:Adolescent; D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage*; D002648:Child; D002675:Child, Preschool; D020031:Epstein-Barr Virus Infections / Q000150:complications / Q000628:therapy; D005047:Etoposide / Q000008:administration & dosage*; D005260:Female; D019337:Hematologic Neoplasms / Q000150:complications / Q000628:therapy; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000150:complications / Q000628:therapy; D051359:Lymphohistiocytosis, Hemophagocytic / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D008297:Male; D012074:Remission Induction; D014184:Transplantation, Homologous
D000972:Antineoplastic Agents, Phytogenic; D005047:Etoposide